Terumo’s Reveos system automates the entire blood-processing procedure. In a single centrifugation cycle, it can separate up to four whole-blood samples into platelets, plasma and red blood cells—a ...
LAKEWOOD, Colo., May 9, 2024 /PRNewswire/ -- Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company, recently received U.S. Food and Drug Administration (FDA) 510(k) clearance ...
BOSTON & LAKEWOOD, Colo.--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, and medical technology ...
The FDA has cleared a plasma collection device developed by Terumo Blood and Cell Technologies (Terumo BCT) and plasma collection network CSL Plasma. The companies, which are subsidiaries of Terumo ...
Automation combined with on-line monitoring during the cell expansion step can bring cell therapy manufacturing efficiencies and enable increased patient accessibility and safety Cell and gene therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results